Rare disease focus Leverage PerkinElmer Genomics expertise in rare diseases and hereditary conditions to pursue partnerships with specialty clinics, rare disease patient advocacy groups, and payers seeking comprehensive diagnostic solutions across preconception to adult care.

Expanded genomic testing Target opportunities around ultrarapid whole genome sequencing and exome sequencing services to hospitals and clinics needing accelerated diagnostic timelines, potentially collaborating on in-house workflows or referral-based programs.

Newborn and pediatric care Position offerings for newborn screening and pediatric genomic testing to maternity hospitals, NICUs, and pediatric practices, highlighting saliva or dried blood spot sample workflows and end-to-diagnostic-odyssey value.

Partnership potential Explore collaborations with pharma and diagnostic players on companion diagnostics, genetic testing panels, and validation studies, informed by past partnerships and joint programs such as anemia testing initiatives.

scalable capabilities Promote scalable testing options (targeted genes, gene panels, whole exome/genome, CNV) to mid-sized labs and regional health systems seeking to expand their genomics services without substantial capex, supported by existing tech stack and cloud-ready workflows.